Recent Articles from GlobeNewswire

Bolsters U.S. public transportation capabilities and deepens presence in a top infrastructure market

CHICAGO and VANCOUVER, British Columbia, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc. (Green Thumb) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of RISE Dispensaries, today announced it will release fourth quarter and full year 2025 financial results after the market closes on Wednesday, February 25, 2026.

Award Recognizes CC Pharma as an Innovative Leader and Trusted Partner in the European Pharmaceutical Market

WATERTOWN, Mass., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of programs that target novel mechanisms of action for a broad range of underserved, prevalent diseases, today announced that the Company will participate in a fireside chat at the Guggenheim Emerging Outlook: Biotech Summit 2026 on Wednesday, February 11, 2026 at 4:00 p.m. ET in New York, NY.

NEW YORK, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Pico, a leading provider of mission-critical technology services, software, data, and analytics for the global financial markets community, today announced continued global expansion of its venue coverage, reinforcing its commitment to enabling clients with seamless, low-latency access to liquidity as markets evolve toward 24/7 trading.

WAYNE, Pa., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company fully dedicated to developing IL-1β-based treatments for immune-mediated inflammatory diseases, today announced that management will participate in the following investor conferences:

WALTHAM, Mass., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein, today announced that management will present at the Guggenheim Securities Emerging Outlook: Biotech Summit 2026 on Wednesday, February 11th, 2026 at 2:00 p.m. ET.

Commissioning marks a major step in building Europe’s hydrogen backbone, positioning Plug as a key end-to-end solutions provider supporting the scale-up of clean hydrogen infrastructure across the continent

REDWOOD CITY, Calif., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by all forms of hyperinsulinism (HI), today announced that management will participate in the Guggenheim Emerging Outlook: Biotech Summit 2026, taking place February 11-12, 2026 in New York.

WATERTOWN, Mass., Feb. 04, 2026 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation (TPD) science, today announced that C4T management will participate in a fireside chat at the Guggenheim Emerging Outlook: Biotech Summit 2026 taking place from February 11 – 12, 2026 in New York, NY.

SHENZHEN, China, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Aurora Mobile Limited (NASDAQ: JG) (“Aurora Mobile” or the “Company”), a leading provider of customer engagement and marketing technology services in China, today announced that Mr. Weidong Luo, Chairman and Chief Executive Officer of Aurora Mobile, was named as a 2025 Greater Bay Area (GBA) Strategic Emerging Industry Youth Leader by the Shenzhen Strategic Emerging Industry Development and Promotion Association. This distinction is in recognition of Mr. Luo’s significant contributions to developer services, big data, and artificial intelligence, as well as his leadership in spearheading Aurora Mobile’s international expansion and the development of its intelligent customer engagement system.

BOSTON, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA) today announced the Company will participate in two upcoming investor conferences.

SOUTH SAN FRANCISCO, Calif., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company developing small molecule precision medicines for patients with kidney and metabolic diseases, today announced that Jason Coloma, Ph.D., chief executive officer of Maze Therapeutics, will present at the Guggenheim Emerging Outlook: Biotech Summit 2026 on Wednesday, February 11, 2026 at 3:00 p.m. ET.

NEW YORK, Feb. 04, 2026 (GLOBE NEWSWIRE) -- ABM (NYSE: ABM) a major provider of facility, engineering, and infrastructure solutions, today completed the previously announced acquisition of WGNSTAR, a leading provider of technical and operational solutions for the semiconductor and high-technology industries.

Advocates breathe sigh of relief as critical CDC program earns congressional support

PARIS, Feb. 04, 2026 (GLOBE NEWSWIRE) -- newcleo, a European developer of advanced nuclear technologies, today announced the close of an USD 85 million1 financing round, bringing total funds raised in the past 12 months to over USD 125 million. This funding round brings total funds raised by the company since 2021 to over USD 755 million.

LOS ANGELES, Feb. 04, 2026 (GLOBE NEWSWIRE) -- WEBTOON Entertainment Inc. (Nasdaq: WBTN) (“WEBTOON Entertainment,” or “the Company”), a leading global entertainment company and home to some of the world’s largest storytelling platforms, today announced that it plans to report fourth quarter and full year 2025 financial results after market close on March 3, 2026. Following the release, the Company’s management team will host a conference call at 4:30 p.m. ET to review the results.

Conference Call to be held Wednesday, February 4 at 9:00 a.m. Central Time

HousingWire recognizes RentRedi’s continued impact on reducing friction in the rental housing industry by helping independent landlords operate smarter, grow confidently, and deliver better rental experiences for tenants

Fundraised a Record $35 Billion in the Fourth Quarter; $112 Billion for 2025

Further production growth to one million ounces annually expected by 2030 through development of Lynn Lake and the Island Gold District Expansion

~ Previously announced Light-Duty divestiture providing non-dilutive capital that strengthens Westport’s cash position~

CHANTILLY, Va., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN) announced today that DroneArmor™, the company’s counter-unmanned aircraft system (C-UAS), has been deployed by a Federal national security customer to enhance security and protect personnel, communities, and critical infrastructure along the United States southern border. The proven, military-grade command and control (C2) system is purpose-built to provide streamlined and autonomous C-UAS protection.

New conversational AI lead response and AI‑powered lead scoring help dealers respond faster, work smarter, and grow more profitably

Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com

Combining Operations Strengthens Position in Defense and Industrial Markets with Enhanced Capacity and Specialized Capabilities

ST GALLEN, Switzerland, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Betfred has extended and expanded its longstanding agreement with Sportradar (NASDAQ: SRAD). As part of the agreement, Sportradar will upgrade the retail platform technology underpinning the operations of Betfred’s 1,300 retail outlets nationwide, ensuring a sustainable and engaging betting offering is available on the UK high street.

Chicago, IL, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Verit Advisors®, a Chicago-based investment banking firm, was engaged by Bloomingdale, Illinois based NOW Health Group (“NOW”), Inc to provide expertise in structuring and executing a partial Employee Stock Ownership Plan (ESOP) transaction and debt capital raise that optimized the Company’s and shareholders’ objectives.  The Verit team was honored to support NOW in this monumental transition which will create meaningful employee benefits and preserve the founder’s legacy for years to come.

Publicis Advances Working With Cancer with initiative to support 40 million workers worldwide. 

The list will be announced on February 16 during CoffeeFest Madrid, after evaluating more than 15,000 coffee shops from around the world

  

EINDHOVEN, the Netherlands, Feb. 04, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD and US OTCQX: ONWRY), the neurotechnology company pioneering spinal cord stimulation therapies to restore movement, function, and independence, today announces the enrollment of the first participant in Empower BP, a global pivotal study assessing the safety and effectiveness of the investigational ARC-IM® System in managing symptomatic blood pressure instability in people with chronic spinal cord injury (SCI).

BOSTON, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Curium Group today announced that together with PeptiDream Inc. and PDRadiopharma Inc., the first patient has been dosed in the companies’ registrational clinical trial of 177Lu-PSMA-I&T in Japan for patients with PSMA (*1)-positive metastatic castration-resistant prostate cancer (mCRPC).

Press release4 February 2026 - N° 03

Equinor (OSE: EQNR, NYSE: EQNR) will on 5 February 2026 commence the first tranche of up to USD 375 million of the share buy-back programme for 2026, as announced in relation with the company’s fourth quarter results on 4 February 2026.

Key information relating to the proposed cash dividend to be paid by Equinor (OSE: EQNR, NYSE: EQNR) for fourth quarter 2025.

Equinor (OSE:EQNR, NYSE:EQNR) delivered an adjusted operating income* of USD 6.20 billion and USD 1.55 billion after tax* in the fourth quarter of 2025. Equinor reported a net operating income of USD 5.49 billion and a net income of USD 1.31 billion. Adjusted net income* was USD 2.04 billion, leading to adjusted earnings per share* of USD 0.81.

York, PA, Feb. 04, 2026 (GLOBE NEWSWIRE) -- ATC Pest Control, a family-operated pest management company serving Pennsylvania and Maryland since 1991, has introduced a bed bug treatment system that combines controlled heat with humidity regulation to improve the effectiveness of thermal remediation. The approach is designed to address growing concerns around chemical resistance in bed bug populations while providing a non-chemical treatment option for residential environments.

NEW YORK and NEW ORLEANS, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Klarna Group plc (“Klarna” or the “Company”) (NYSE: KLAR) of a class action securities lawsuit.

NEW YORK CITY and NEW ORLEANS, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in CoreWeave, Inc. (“CoreWeave” or the “Company”) (NasdaqGS: CRWV) of a class action securities lawsuit.

NEW YORK and NEW ORLEANS, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until February 17, 2026 to file lead plaintiff applications in a securities class action lawsuit against F5, Inc. (NasdaqGS: FFIV), if they purchased or otherwise acquired the Company’s securities between October 28, 2024, and October 27, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Western District of Washington.

NEW YORK and NEW ORLEANS, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until February 9, 2026 to file lead plaintiff applications in a securities class action lawsuit against Integer Holdings Corporation (“Integer” or the “Company”) (NYSE: ITGR), if they purchased or otherwise acquired the Company’s shares between July 25, 2024 and October 22, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.

NEW YORK CITY and NEW ORLEANS, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Coupang, Inc. (“Coupang” or the “Company”) (NYSE: CPNG) of class action securities lawsuits.

NEW YORK and NEW ORLEANS, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until March 23, 2026 to file lead plaintiff applications in a securities class action lawsuit against BellRing Brands, Inc. (NYSE: BRBR), if they purchased or otherwise acquired the Company’s securities between November 19, 2024 and August 4, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.

NEW YORK and NEW ORLEANS, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until March 9, 2026 to file lead plaintiff applications in a securities class action lawsuit against Ardent Health, Inc. (“Ardent” or the “Company”) (NYSE: ARDT), if they purchased or otherwise acquired the Company’s securities between July 18, 2024 and November 12, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Middle District of Tennessee.

LEXINGTON, Mass., Feb. 03, 2026 (GLOBE NEWSWIRE) -- MiNK Therapeutics (Nasdaq: INKT) today announced that new translational data supporting the role of invariant natural killer T (iNKT) cells in idiopathic pulmonary fibrosis (IPF) were presented at the Emerging Cell Therapies Meeting of the Keystone Symposia on Molecular and Cellular Biology, taking place February 1–4, 2026, in Banff, Alberta, Canada.

DALLAS, Feb. 03, 2026 (GLOBE NEWSWIRE) -- The March/April print edition of SUCCESS® has officially arrived at newsstands, centered on the theme of Intelligence. Headlined by actress and neuroscientist Mayim Bialik, this issue moves beyond theory to offer readers a tactical look at mental wellness, professional innovation and cognitive edge. It is designed for the modern achiever who views lifelong learning as their most valuable asset.

Harford County, MD, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Maryland Windows and Doors, a family-owned window and door replacement company serving Greater Baltimore for more than 45 years, has announced the expansion of its service capacity to meet rising homeowner demand for energy-efficient window replacements. The expanded capacity will support faster scheduling, faster installation availability, and homeowner education as more Maryland households look for practical ways to manage winter heating costs.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Beta Bionics To Contact Him Directly To Discuss Their Options

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Aquestive Therapeutics To Contact Him Directly To Discuss Their Options

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In F5 To Contact Him Directly To Discuss Their Options

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Wealthfront To Contact Him Directly To Discuss Their Options

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Fermi To Contact Him Directly To Discuss Their Options

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Gauzy To Contact Him Directly To Discuss Their Options

New York, NY, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Colombier Acquisition Corp. III (the “Company,” “Colombier III”) today announced the pricing of its initial public offering of 26,000,000 units at a price of $10.00 per unit. The units will be listed on the New York Stock Exchange (“NYSE”) and trade under the ticker symbol “CLBR U” beginning on February 4, 2026. Each unit consists of one Class A ordinary share and one-eighth of one redeemable warrant, with each whole warrant exercisable to purchase one Class A ordinary share at a price of $11.50 per share. After the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on the NYSE under the symbols “CLBR” and “CLBR WS,” respectively.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Rezolute To Contact Him Directly To Discuss Their Options

All amounts are in United States dollars, unless otherwise stated

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In SLM To Contact Him Directly To Discuss Their Options

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Klarna To Contact Him Directly To Discuss Their Options

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered In Ramaco To Contact Him Directly To Discuss Their Options

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In agilon health To Contact Him Directly To Discuss Their Options

Framework Agreement Identifies Focus Areas for Cooperation in Research, Education, and Innovation

37604, Feb. 03, 2026 (GLOBE NEWSWIRE) -- JOHNSON CITY, Tenn. – Ballad Health announced Mike Anderes, FACHE, as managing director of Ballad Ventures. Anderes has relocated to Northeast Tennessee, bringing 30 years of experience in healthcare innovation, digital transformation and system strategy to support Ballad Health’s mission to improve health in the Appalachian Highlands.

Houston, TX, Feb. 03, 2026 (GLOBE NEWSWIRE) -- This is a monumental moment for veteran services. Combined Arms is honored to support bipartisan legislation to create a National Veterans Strategy.

Changing pharmacy payment model must protect patients, pharmacies, NCPA says

Washington, DC, Feb. 03, 2026 (GLOBE NEWSWIRE) -- National Association of Specialty Pharmacy (NASP) President and CEO Sheila Arquette, R.Ph. and Chairman of the Board Scott Guisinger issued a statement today as President Trump signed into law legislation to fund the majority of government programs and for the first time enact pharmacy benefit manager (PBM) reforms aimed at protecting specialty pharmacies and their patients.

Veteran health care finance leader Adrienne Moore to drive strategic vision and growth for nonprofit health system

PHILADELPHIA, Pa., Feb. 03, 2026 (GLOBE NEWSWIRE) -- National plaintiffs’ law firm Berger Montague PC advises shareholders of Stride, Inc. (NYSE: LRN) (“Stride” or the “Company”) about an investigation into Stride’s Board of Directors (the “Board”) for potential breaches of fiduciary duties owed to the Company and its shareholders, including whether the Board failed to exercise appropriate oversight and governance in connection with the Company’s and its executives’ public statements regarding Stride’s operations and financial performance.

RONKONKOMA, N.Y., Feb. 03, 2026 (GLOBE NEWSWIRE) -- SUNation Energy Inc. (Nasdaq: SUNE) (“SUNation” or the “Company”), a leading provider of sustainable solar energy and backup power solutions to residential, commercial, and municipal customers, today announced that it has eliminated the remainder of approximately $1.1M (of an original $2.5m) and substantially reduced its monthly repayments related to a long-term debt obligation of its wholly-owned subsidiary SUNation Solar Systems, significantly improving ongoing cash flow and strengthening the Company’s balance sheet.

Exhibit 99.1

WEST PALM BEACH, Fla., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Solitron Devices, Inc. (OTC Pink: SODI) (“Solitron” or the “Company”) is announcing that the Company’s Board of Directors has set April 24, 2026 as its annual meeting date and has decided to pursue the exploration of potential transactions including merger or sale opportunities.